Pfizer (PFE) raises outlook on hopes of prescription trends recovery and COVID-19 vaccine progress
Shares of Pfizer Inc. (NYSE: PFE) were up more than 4% on Tuesday after the company beat revenue and earnings...
Shares of Pfizer Inc. (NYSE: PFE) were up more than 4% on Tuesday after the company beat revenue and earnings...
Pfizer Inc. (NYSE:PFE) reported second quarter 2020 earnings results today. Revenues fell 11% to $11.8 billion. The decline was 9%...
Trxade Group Inc. (NASDAQ: MEDS) Q2 2020 earnings call dated July 27, 2020 Corporate Participants: Suren Ajjarapu — Founder, Chairman and Chief...
Quest Diagnostics Inc (NYSE: DGX) Q2 2020 earnings call dated July 23, 2020 Corporate Participants: Shawn Bevec — Vice President, Investor Relations...
Quest Diagnostics (NYSE: DGX) reported second-quarter financial results before the regular market hours on Thursday. The Q2 earnings were a...
Align Technology Inc. (NASDAQ: ALGN) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Shirley Stacy — Vice President, Corporate and...
IQVIA Holdings Inc. (NYSE: IQV) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Andrew Markwick — Senior Vice President, Investor...
Thermo Fisher Scientific Inc. (NYSE: TMO) Q2 2020 earnings call dated Jul. 22, 2020 Corporate Participants: Kenneth Apicerno — Vice President, Investor...
Biogen Inc. (NASDAQ: BIIB) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Joe Mara — Vice President of Finance and...
Novartis International AG (NYSE: NVS) Q2 2020 earnings call dated Jul. 21, 2020 Corporate Participants: Samir Shah — Global Head of Investor...
Biogen (NASDAQ: BIIB) reported a 12% increase in adjusted EPS and 2% growth in revenue for the second quarter of...
Thermo Fisher Scientific Inc. (NYSE: TMO) today announced its second quarter financial results for the period ended June 27, 2020....
Intuitive Surgical, Inc. (NASDAQ: ISRG) reported second quarter 2020 earnings results today. Revenues decreased 22% year-over-year to $852 million, due...
Thanks to the COVID-19 testing growth, after reporting solid second quarter results and strong outlook for fiscal 2020 last Thursday,...
AngioDynamics, Inc. (NASDAQ: ANGO) Q4 2020 earnings call dated July 16, 2020 Corporate Participants: Jim Clemmer — President and Chief Executive Officer...
Abbott Laboratories (NYSE: ABT) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Scott Leinenweber — Vice President, Investor Relations, Licensing...
Johnson & Johnson (NYSE: JNJ) Q2 2020 earnings call dated July 16, 2020 Corporate Participants: Chris DelOrefice — Vice President, Investor Relations...
Johnson & Johnson (NYSE: JNJ) saw revenue and earnings decline for the second quarter of 2020 but both the top...
Abbott Laboratories (NYSE: ABT) reported second-quarter financial results before the regular trading hours on Thursday. Revenue for the quarter fell...
AngioDynamics, Inc. (NASDAQ: ANGO) today announced its fourth quarter financial results for the period ended May 31, 2020. Net loss...
Johnson & Johnson (NYSE: JNJ) reported second quarter 2020 earnings results today. Reported sales decreased 10.8% to $18.3 billion. GAAP...